Albertsons beats Q4 profit estimates, raises dividend 13%

Albertsons Companies

14/04/2026 12:42

Corrects headline to show adjusted profit, not net profit, beat estimates; corrects dividend in the Key Details table to $0.15 from $0.17; clarifies in Overview bullet that dividend was subsequently increased to $0.17

Overview

U.S. food and drug retailer's fiscal Q4 revenue slightly missed analyst expectations

Adjusted EPS for fiscal Q4 beat analyst expectations

Company raised quarterly dividend 13% to $0.17 and increased share repurchase authorization to $2 bln

Posts Q4 net loss of $481 mln, inclusive of a $600 mln charge related to settling all opioid-related claims

Outlook

Albertsons sees fiscal 2026 identical sales growth of 0.0% to 1.0%

Company expects fiscal 2026 adjusted EBITDA of $3.85 bln to $3.925 bln

Albertsons expects a 150 basis point headwind to identical sales from IRA Medicare Drug Price Negotiation

Result Drivers

PHARMACY HEADWINDS - Identical sales growth was primarily driven by pharmacy sales, but these were negatively impacted by pricing headwinds from the Inflation Reduction Act and industry mix shifts

DIGITAL SALES GROWTH - Digital sales increased 16% in Q4, contributing to overall revenue growth

EXTRA WEEK IMPACT - Net sales and Adjusted EBITDA benefited from an extra week in the quarter, adding approximately $1.4 bln in sales and $68 mln in Adjusted EBITDA

Company press release: ID:nBw2BFYhwa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Slight Miss*
$20.30 bln
$20.47 bln (15 Analysts)
Q4 Adjusted EPS
Beat
$0.48
$0.43 (18 Analysts)
Q4 EPS
-$0.94
Q4 Adjusted Net Income
Beat
$252 mln
$221.06 mln (12 Analysts)
Q4 Dividend
$0.15
Q4 Identical Sales Growth
0.70%


*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", 6 "hold" and 2 "sell" or "strong sell"

The average consensus recommendation for the food retail & distribution peer group is "buy"

Wall Street's median 12-month price target for Albertsons Companies Inc is $22.50, about 33.5% above its April 13 closing price of $16.85

The stock recently traded at 7 times the next 12-month earnings vs. a P/E of 8 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)